Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / CYDY - CytoDyn's PRO 140 shows sustained effect in HIV study

CYDY - CytoDyn's PRO 140 shows sustained effect in HIV study

CytoDyn Inc
  • Updated results from an HIV clinical trial evaluating escalating doses of CytoDyn's (OTCQB:CYDY -0.1%) PRO 140 (leronlimab) showed sustained viral load suppression at ~one year.
  • More news on: CytoDyn Inc., Healthcare stocks news,
    • Read more ...
Stock Information
Company Name: CytoDyn Inc
Stock Symbol: CYDY
Market: OTC
Website: cytodyn.com
Menu
CYDY CYDY Quote CYDY Short CYDY News CYDY Articles CYDY Message Board
Get CYDY Alerts

News, Short Squeeze, Breakout and More Instantly...